Clinical trial
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With…
NCT00004934 · Nordic Society of Gynaecological Oncology - Clinical Trials Unit, Other · Completed
Key facts
| NCT number | NCT00004934 |
|---|---|
| Title | Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer |
| Official title | A Randomized Trial of Paclitaxel/Epirubicin/Carboplatin Combination (TEC) Versus Paclitaxel/Carboplatin (TC) in the Treatment of Women With Advanced Ovarian Cancer |
| Lead sponsor | Nordic Society of Gynaecological Oncology - Clinical Trials Unit, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, epirubicin hydrochloride, paclitaxel, conventional surgery |
| Start date | Aug 1, 1999 |
| Completion | May 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 4, 2013 |
| Countries | Belgium, Canada, Denmark, Israel, Italy, Netherlands, Norway, Portugal, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: